# Performance of the CARDIOGARD Cannula

Study · id `cardio:ct-nct02764645` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02764645](<https://clinicaltrials.gov/study/NCT02764645>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT02764645

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease; Valve and congenital heart disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 400 participants.

## Technical summary

Registry record NCT02764645. Randomized; single masking; primary purpose prevention. Start 2016-05 (registry gives no type); primary completion 2017-05 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose prevention
- Phase: Not applicable
- Enrolled: 400 participants (planned count; ClinicalTrials.gov record NCT02764645, source copy `cardio:ctgov-nct02764645-2016-05-06`, retrieved 2026-10-26)
- Start date: 2016-05 (registry gives no type) (ClinicalTrials.gov record NCT02764645, source copy `cardio:ctgov-nct02764645-2016-05-06`, retrieved 2026-10-26)
- Primary completion: 2017-05 (anticipated) (ClinicalTrials.gov record NCT02764645, source copy `cardio:ctgov-nct02764645-2016-05-06`, retrieved 2026-10-26)
- Completion: 2019-05 (anticipated) (ClinicalTrials.gov record NCT02764645, source copy `cardio:ctgov-nct02764645-2016-05-06`, retrieved 2026-10-26)
- Countries: Not reported
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02764645-2016-05-06`, retrieved 2026-10-26)

## The registry's words

- Brief title: Performance of the CARDIOGARD Cannula
- Acronym: GECG
- Condition: Heart Valve Diseases
- Condition: Coronary Artery Disease
- Intervention (Device): CardioGard Cannula
- Intervention (Device): 22Fr curved Cannula
- Lead sponsor: Rambam Health Care Campus
- Lead sponsor class: OTHER
- Collaborator: CardioGard Medical Ltd.
- Collaborator class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Coronary artery disease (`cardio:coronary-artery-disease`)
- Registry condition terms include this condition: Heart valve disease (`cardio:heart-valve-disease`)
- Registry lists this organization as the lead sponsor: Rambam Health Care Campus (`cardio:org-rambam-health-care-campus`)

## Provenance

Content hash: e589de334cea352d153d1defe281b7466ab99f0c77f11d4fda81499dc1737aea
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
